Eyeworld

OCT 2018

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1035656

Contents of this Issue

Navigation

Page 95 of 142

93 EW CORNEA October 2018 Petris: rebecca@dryeyecompany.com Shah: rupas@revisioneyes.com Zashin: szashin823@aol.com of medicine, University of Texas Southwestern Medical School, Dal- las, thinks is critical for treatment. "I think it's important that all my Sjögren's patients are under the care of an ophthalmologist as they almost all have dry eyes," he said. When his patients continue to have dry eye issues despite treatment, he will refer them to an ophthalmol- ogist or corneal specialist with an interest in dry eye. Looking for other treatments Physicians are looking ahead to other options that may be useful in the future. Although the TrueTear neu- rostimulator device (Allergan) is new to the market, Ms. Petris has seen positive comments about it in social media groups. TrueTear helps patients increase production of their own tears. She also has seen a growing interest in dry eye glasses to manage symptoms. Dr. Shah is interested in both TrueTear and Dextenza (Ocular Therapeutix, Bedford, Massachu- setts), a low-dose dexamethasone delivery system within a punctal plug. "This may prove promising for Sjögren's patients who have severe inflammation," she said. There is interest in biologic therapy to treat Sjögren's patients. For example, Dr. Zashin took part in a clinical trial with the rheumatoid arthritis drug Orencia (abatacept, Bristol-Myers Squibb, New York) to treat Sjögren's. However, results are not yet published. Dr. Akpek would like to see more consideration of dry eye and Sjögren's syndrome as pharmaceutical companies test or expand biologic indications and in- dications for other medications. EW References 1. Sjögren's Syndrome Foundation. Living with Sjögren's 2016. www.sjogrens.org/home/ about-sjogrens/livingwithsjogrenssurvey 2. Sjögren's Syndrome Foundation. About Sjögren's/Diagnosis. www.sjogrens.org/home/ about-sjogrens/diagnosis 3. Vivino FB. Sjögren's syndrome: Clinical aspects. Clin Immunol. 2017;182:48–54. 4. Gonzales JA, et al. How are ocular signs and symptoms of dry eye associated with depression in women with and without Sjögren syndrome? Am J Ophthalmol. 2018;191:42–48. Editors' note: The sources have no financial interests related to their comments. Contact information Akpek: esakpek@jhmi.edu Ozerov: iozerov@gmail.com Patel: rapatel5462@gmail.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - OCT 2018